BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12081234)

  • 1. A modified hMG-GnRH method for the induction of ovulation in infertile women with severe hypogonadotropic amenorrhea.
    Yokoi N; Uemura T; Murase M; Kondoh Y; Ishikawa M; Hirahara F
    Endocr J; 2002 Apr; 49(2):159-64. PubMed ID: 12081234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of ovulation in amenorrheic patients with gonadotropin-releasing hormone and human menopausal gonadotropin.
    Eckstein N; Vagman I; Eshel A; Naor Z; Ayalon D
    Fertil Steril; 1985 Dec; 44(6):744-50. PubMed ID: 3935484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
    Blumenfeld Z; Lang N; Amit A; Kahana L; Yoffe N
    Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders.
    Saffan D; Seibel MM
    Fertil Steril; 1986 Apr; 45(4):475-82. PubMed ID: 3082681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induction of ovulation by a luteinizing hormone releasing hormone pump. Principles, indications and results].
    Gompel A; de Plunkett T; Mandelbaum J; Mauvais-Jarvis P
    Presse Med; 1985 Apr; 14(17):963-6. PubMed ID: 3158932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of follicle maturation and ovulation by gonadotropin administration in women with beta-thalassemia.
    Danesi L; Scacchi M; Miragoli AM; Pincelli AI; Dubini A; Maiolo AT; Cavagnini F; Polli EE
    Eur J Endocrinol; 1994 Dec; 131(6):602-6. PubMed ID: 7804443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea.
    Martin KA; Hall JE; Adams JM; Crowley WF
    J Clin Endocrinol Metab; 1993 Jul; 77(1):125-9. PubMed ID: 8325934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsatile GnRH therapy for the induction of ovulation in hypogonadotropic hypogonadism.
    Blunt SM; Butt WR
    Acta Endocrinol Suppl (Copenh); 1988; 288():58-65. PubMed ID: 3138867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility.
    Felberbaum RE; Reissmann T; Küpker W; Bauer O; al Hasani S; Diedrich C; Diedrich K
    Eur J Obstet Gynecol Reprod Biol; 1995 Aug; 61(2):151-5. PubMed ID: 7556837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of ovulation with luprolide acetate and human menopausal gonadotropin.
    Lewinthal D; Taylor PJ; Pattinson HA; Corenblum B
    Fertil Steril; 1988 Apr; 49(4):585-8. PubMed ID: 3127242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does polycystic ovarian morphology influence the response to treatment with pulsatile GnRH in functional hypothalamic amenorrhea?
    Dumont A; Dewailly D; Plouvier P; Catteau-Jonard S; Robin G
    Reprod Biol Endocrinol; 2016 Apr; 14(1):24. PubMed ID: 27129705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ovulation induction with pulsatile gonadotropin-releasing hormone and continuous human menopausal gonadotropin in polycystic ovarian disease].
    Kuroda G
    Nihon Naibunpi Gakkai Zasshi; 1987 Mar; 63(3):247-59. PubMed ID: 3111899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful pregnancies in patients with estrogenic anovulation after low-dose human chorionic gonadotropin therapy alone following hMG for controlled ovarian hyperstimulation.
    Lee KL; Couchman GM; Walmer DK
    J Assist Reprod Genet; 2005 Jan; 22(1):37-40. PubMed ID: 15807221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of single ovulation by sequential follicle-stimulating hormone and pulsatile gonadotropin-releasing hormone treatment.
    Kuwahara A; Matsuzaki T; Kaji H; Irahara M; Aono T
    Fertil Steril; 1995 Aug; 64(2):267-72. PubMed ID: 7615101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovulation induction with pulsatile gonadotropin-releasing hormone (GnRH) or gonadotropins in a case of hypothalamic amenorrhea and diabetes insipidus.
    Georgopoulos NA; Markou KB; Pappas AP; Protonatariou A; Vagenakis GA; Sykiotis GP; Dimopoulos PA; Tzingounis VA
    Gynecol Endocrinol; 2001 Dec; 15(6):421-5. PubMed ID: 11826765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
    Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
    J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.